For FY2026 Q2, net sales amounted to 53.218 billion yen, a 9.3% increase year-over-year, operating income was 2.801 billion yen, up 20.6%, and the full-year earnings guidance has been revised upward to sales of 221.2 billion yen and operating income of 11.05 billion yen.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"9267","jir_company_name":"Genky DrugStores Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-01-27","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/01\/9267-20260127-03.pdf","jir_short_summary":"For FY2026 Q2, net sales amounted to 53.218 billion yen, a 9.3% increase year-over-year, operating income was 2.801 billion yen, up 20.6%, and the full-year earnings guidance has been revised upward to sales of 221.2 billion yen and operating income of 11.05 billion yen.","jir_summary":"### Performance Overview\nFor FY2026 Q2, net sales totaled 53,218 million yen, a 9.3% increase year-over-year, and operating income reached 2,801 million yen, up 20.6%. Gross profit margin improved to 20.54% from 20.13% in the same period last year. Although selling, general and administrative expenses underperformed compared to the plan, appropriate control of working hours led to operating income exceeding the plan by 140 million yen. New store openings numbered 17, nearly on target with the initial plan of 18 stores. Same-store sales rose steadily by 2.5%, slightly below the planned 2.6% increase.\n\n### Revision of Full-Year Earnings Guidance\nThe full-year earnings guidance for FY2026 has been revised, with net sales forecasted at 221.2 billion yen (up 10.2% year-over-year) and operating income projected at 11.05 billion yen (up 14.4%). Gross profit margin is assumed at 20.4%, and SG&A expense ratio at 15.4%. The plan includes 61 new store openings and 3 store closures (including large-scale stores). Earnings per share (EPS) is expected to be 257.5 yen. The company aims to improve sales and operating income per unit area through its EDLP strategy while continuing to reduce expense ratios.","jir_financial_highlights":"Net Sales: 53,218 million yen (Year-over-Year +9.3%)\nOperating Income: 2,801 million yen (Year-over-Year +20.6%)\nOrdinary Income: 2,883 million yen (Year-over-Year +19.1%)\nQuarterly Net Income: 1,983 million yen (Year-over-Year +17.8%)\nNew Store Openings: 17 stores (Year-over-Year +8 stores)\nFull-Year Net Sales Forecast: 221,200 million yen (Year-over-Year +10.2%)\nFull-Year Operating Income Forecast: 11,050 million yen (Year-over-Year +14.4%)","jir_category":"","jir_hashtags":"#GenkyDrugStores, #FinancialResultsPresentation, #JapaneseStocks","jir_key_figures":"Net Sales (2Q Actual): 53,218 million yen (Year-over-Year +9.3%)\nOperating Income (2Q Actual): 2,801 million yen (Year-over-Year +20.6%)\nFull-Year Operating Income Forecast (Revised): 11,050 million yen (Year-over-Year +14.4%)","jir_meta_title":"Genky DrugStores FY2026 Q2 Financial Results \u2013 Net Sales up 9.3%, Operating Income up 20.6%","jir_meta_description":"Financial results presentation materials for Genky DrugStores Co., Ltd. FY2026 Q2 net sales of 53,218 million yen (up 9.3% YoY), operating income of 2,801 million yen (up 20.6% YoY), with upward revision of full-year earnings guidance.","jir_og_title":"Genky DrugStores FY2026 Q2 Financial Results Announcement","jir_og_description":"Net sales up 9.3%, operating income up 20.6%. Earnings guidance revised upward, indicating continued growth in the financial results presentation.","jir_og_image_url":"\/assets\/og\/company-financial_summary.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Net Sales Trend (FY2024\u2013FY2026 Q1\u2013Q2)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"1Q FY2024\\\",\\\"2Q FY2024\\\",\\\"1Q FY2025\\\",\\\"2Q FY2025\\\",\\\"1Q FY2026\\\",\\\"2Q FY2026\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net Sales (million yen)\\\",\\\"data\\\":[46871,45095,50050,48708,56042,53218],\\\"borderColor\\\":\\\"#007bff\\\",\\\"fill\\\":false}]},\\\"options\\\":{\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Operating Income Trend (FY2024\u2013FY2026 Q1\u2013Q2)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"1Q FY2024\\\",\\\"2Q FY2024\\\",\\\"1Q FY2025\\\",\\\"2Q FY2025\\\",\\\"1Q FY2026\\\",\\\"2Q FY2026\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Income (million yen)\\\",\\\"data\\\":[2015,2371,2272,2323,2916,2801],\\\"borderColor\\\":\\\"#28a745\\\",\\\"fill\\\":false}]},\\\"options\\\":{\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"margin_analysis\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Gross Profit Margin, SG&A Expense Ratio and Operating Income Margin Trends\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"1Q FY2024\\\",\\\"2Q FY2024\\\",\\\"1Q FY2025\\\",\\\"2Q FY2025\\\",\\\"1Q FY2026\\\",\\\"2Q FY2026\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Gross Profit Margin (%)\\\",\\\"data\\\":[19.9,20.9,20.2,20.1,20.2,20.5],\\\"borderColor\\\":\\\"#ff6384\\\",\\\"fill\\\":false},{\\\"label\\\":\\\"SG&A Expense Ratio (%)\\\",\\\"data\\\":[15.6,15.7,15.0,15.4,15.3,15.3],\\\"borderColor\\\":\\\"#36a2eb\\\",\\\"fill\\\":false},{\\\"label\\\":\\\"Operating Income Margin (%)\\\",\\\"data\\\":[4.3,5.3,4.5,4.8,5.2,5.3],\\\"borderColor\\\":\\\"#ffce56\\\",\\\"fill\\\":false}]},\\\"options\\\":{\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true,\\\"max\\\":25}}}}\"}]","ir_related_company":9174,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-21036","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n